Federal Register / Vol. 86, No. 164 / Friday, August 27, 2021 / Notices 48147 

require changes in the scope of the 

project. This Revision includes; (a) 

modification of the Instructions to 

Participants Letter; (b) modification of 

the MPEP Mycobacterium tuberculosis 

Results Worksheet; (c) modification of 

online data collection instrument; (d) 

modification of the MPEP 

Mycobacterium tuberculosis Minimum 

Inhibitory Concentration Results 

Worksheet; (e) removal of Reminder 

Telephone Script; and (f) modification 

of Aggregate Report Letter. 

While the overall number of cases of 

TB in the U.S. has decreased, rates still 

remain high among foreign-born 

persons, corrections, homeless 

populations, and individuals infected 

with HIV in major metropolitan areas. 

To reach the goal of eliminating TB, the 

Model Performance Evaluation Program 

for Mycobacterium tuberculosis 

susceptibility testing is used to monitor 

and evaluate performance and practices 

among US laboratories performing M. 

tuberculosis susceptibility testing. 

Participation in this program is one way 

laboratories can ensure high-quality 

laboratory testing, resulting in accurate 

and reliable testing results. 

By providing an evaluation program 

to assess the ability of laboratories to 

test for drug resistant M. tuberculosis 

strains, CDC gives laboratories a selfassessment tool to aid in optimizing 

their skills in susceptibility testing. The 

information obtained from the 

laboratories on susceptibility practices 

and procedures is used to establish 

variables related to good performance, 

assess training needs, and aid with the 

development of practice standards. 

Participants in this program include 

domestic clinical and public health 

laboratories. Data collection from 

laboratory participants occurs twice per 

year. The data collected in this program 

will include the susceptibility test 

results of primary and secondary drugs, 

drug concentrations, and test methods 

performed by laboratories on a set of 

performance evaluation (PE) isolates. 

The PE isolates are sent to participants 

twice a year, and participants also 

report demographic data such as 

laboratory type and the number of drug 

susceptibility tests performed annually. 

CDC requests approval for an 

estimated 129 burden hours annually. 

There is no cost to respondents to 

participate other than their time. 

ESTIMATED ANNUALIZED BURDEN HOURS

Type of respondents Form name Number of 

respondents 

Number of 

responses per 

respondent 

Average 

burden per 

response 

(in hours) 

Total burden 

(in hours) 

Domestic Laboratory ..... Participant Biosafety Compliance Letter of 

Agreement.

80 1 5/60 7 

MPEP Mycobacterium tuberculosis Results 

Worksheet.

80 2 30/60 80 

Online Survey Instrument .................................... 80 2 15/60 40 

MPEP Mycobacterium tuberculosis Minimum Inhibitory Concentration Results Form.4 2 15/60 2 

Total ........................ .............................................................................. ........................ ........................ ........................ 129 

Jeffrey M. Zirger, 

Lead, Information Collection Review Office, 

Office of Scientific Integrity, Office of Science, 

Centers for Disease Control and Prevention. 

[FR Doc. 2021–18541 Filed 8–26–21; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Board of Scientific Counselors, 

National Center for Health Statistics 

(BSC, NCHS) 

AGENCY: Centers for Disease Control and 

Prevention (CDC), Department of Health 

and Human Services (HHS). 

ACTION: Notice of meeting. 

SUMMARY: In accordance with the 

Federal Advisory Committee Act, the 

CDC announces the following meeting 

for the Board of Scientific Counselors, 

National Center for Health Statistics 

BSC, NCHS). This meeting is open to 

the public. 

DATES: The meeting will be held on 

October 22, 2021, from 11:00 a.m. to 

5:30 p.m., EDT. 

ADDRESSES: Instructions to access the 

meeting are posted on the BSC website: 

https://www.cdc.gov/nchs/about/bsc/ 

bsc_meetings.htm. 

FOR FURTHER INFORMATION CONTACT: 

Rebecca Hines, M.H.S., Executive 

Secretary, NCHS/CDC, Board of 

Scientific Counselors, 3311 Toledo 

Road, Room 2627, Hyattsville, Maryland 

20782, Telephone: (301) 458–4717; 

Email: RSHines@cdc.gov. 

SUPPLEMENTARY INFORMATION: 

Purpose: The Board is charged with 

providing advice and making 

recommendations to the Secretary, 

Department of Health and Human 

Services; the Director, CDC; and the 

Director, NCHS, regarding the scientific 

and technical program goals and 

objectives, strategies, and priorities of 

NCHS. 

Matters To Be Considered: The 

meeting agenda includes welcome 

remarks and a Center update by the 

NCHS Director; updates on Data 

Modernization (DMI), including 

Epidemiology and Laboratory Capacity 

for Prevention and Control of Emerging 

Infectious Diseases (ELC) Collaboration; 

an update on the National Center for 

Health Statistics Strategic Planning; 

presentation on the NCHS Health Equity 

Strategy; updates on using the National 

Health Interview Survey (NHIS) as a 

platform for additional data collection; 

and an update on several NCHS 

Programs. Agenda items are subject to 

change as priorities dictate. 

Meeting Information: Please visit the 

BSC website: https://www.cdc.gov/nchs/ 

about/bsc/bsc_meetings.htm for more 

information on the meeting agenda, 

including instructions for accessing the 

live meeting broadcast. 

The Board will reserve time for public 

comment at the end of the day. 

The Director, Strategic Business 

Initiatives Unit, Office of the Chief 

Operating Officer, Centers for Disease 

Control and Prevention, has been 

delegated the authority to sign Federal 

Register notices pertaining to 

announcements of meetings and other 

committee management activities, for 

both the Centers for Disease Control and 


lotter on DSK11XQN23PROD with NOTICES1
48148 Federal Register / Vol. 86, No. 164 / Friday, August 27, 2021 / Notices 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Kalwant Smagh, 

Director, Strategic Business Initiatives Unit, 

Office of the Chief Operating Officer, Centers 

for Disease Control and Prevention. 

[FR Doc. 2021–18454 Filed 8–26–21; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Advisory Board on Radiation and 

Worker Health (ABRWH), 

Subcommittee for Dose 

Reconstruction Reviews (SDRR), 

National Institute for Occupational 

Safety and Health (NIOSH); 

Cancellation of Meeting 

Notice is hereby given of a change in 

the meeting of the Advisory Board on 

Radiation and Worker Health (ABRWH), 

Subcommittee for Dose Reconstruction 

Reviews (SDRR); June 16, 2021, from 

10:30 a.m. to 2:30 p.m., EDT, in the 

original FRN. The teleconference 

meeting was published in the Federal 

Register on April 23, 2021, Volume 86, 

Number 77, pages 21738–21739. 

This meeting is being canceled in its 

entirety. 

FOR FURTHER INFORMATION CONTACT: 

Rashaun Roberts, Ph.D., Designated 

Federal Officer, NIOSH, CDC, 1090 

Tusculum Avenue, Mailstop C–24, 

Cincinnati, Ohio 45226, Telephone: 

(513) 533–6800, Toll Free 1(800) CDC– 

INFO, Email: ocas@cdc.gov. 

The Director, Strategic Business 

Initiatives Unit, Office of the Chief 

Operating Officer, Centers for Disease 

Control and Prevention, has been 

delegated the authority to sign Federal 

Register notices pertaining to 

announcements of meetings and other 

committee management activities, for 

both the Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Kalwant Smagh, 

Director, Strategic Business Initiatives Unit, 

Office of the Chief Operating Officer, Centers 

for Disease Control and Prevention. 

[FR Doc. 2021–18455 Filed 8–26–21; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[30Day–21–1061] 

Agency Forms Undergoing Paperwork 

Reduction Act Review 

In accordance with the Paperwork 

Reduction Act of 1995, the Centers for 

Disease Control and Prevention (CDC) 

has submitted the information 

collection request titled Behavioral Risk 

Factor Surveillance System (BRFSS), to 

the Office of Management and Budget 

(OMB) for review and approval. CDC 

previously published a ‘‘Proposed Data 

Collection Submitted for Public 

Comment and Recommendations’’ 

notice on March 12, 2021 to obtain 

comments from the public and affected 

agencies. CDC did not receive comments 

related to the previous notice. This 

notice serves to allow an additional 30 

days for public and affected agency 

comments. 

CDC will accept all comments for this 

proposed information collection project. 

The Office of Management and Budget 

is particularly interested in comments 

that: 

(a) Evaluate whether the proposed 

collection of information is necessary 

for the proper performance of the 

functions of the agency, including 

whether the information will have 

practical utility; 

(b) Evaluate the accuracy of the 

agencies estimate of the burden of the 

proposed collection of information, 

including the validity of the 

methodology and assumptions used; 

(c) Enhance the quality, utility, and 

clarity of the information to be 

collected; 

(d) Minimize the burden of the 

collection of information on those who 

are to respond, including, through the 

use of appropriate automated, 

electronic, mechanical, or other 

technological collection techniques or 

other forms of information technology, 

e.g., permitting electronic submission of 

responses; and 

(e) Assess information collection 

costs. 

To request additional information on 

the proposed project or to obtain a copy 

of the information collection plan and 

instruments, call (404) 639–7570. 

Comments and recommendations for the 

proposed information collection should 

be sent within 30 days of publication of 

this notice to www.reginfo.gov/public/ 

do/PRAMain. Find this particular 

information collection by selecting 

‘‘Currently under 30-day Review—Open 

for Public Comments’’ or by using the 

search function. Direct written 

comments and/or suggestions regarding 

the items contained in this notice to the 

Attention: CDC Desk Officer, Office of 

Management and Budget, 725 17th 

Street NW, Washington, DC 20503 or by 

fax to (202) 395–5806. Provide written 

comments within 30 days of notice 

publication. 

Proposed Project 

Behavioral Risk Factor Surveillance 

System (BRFSS) (OMB Control No. 

0920–1061, Exp. 3/31/2022)— 

Revision—National Center for Chronic 

Disease and Public Health Protection 

(NCCDPHP), Centers for Disease Control 

and Prevention (CDC). 

Background and Brief Description 

CDC is requesting OMB approval to 

revise information collection activities 

for the Behavioral Risk Factor 

Surveillance System (BRFSS) for the 

period of 2022–2024. The BRFSS is a 

nationwide system of cross-sectional 

surveys using random digit dialed 

(RDD) samples administered by health 

departments in states, territories, and 

the District of Columbia (collectively 

referred to here as States) in 

collaboration with CDC. Traditionally 

subject recruitment and interview have 

been conducted by telephone. In 2022– 

2024, the BRFSS will introduce the 

option to allow participants to 

voluntarily complete online surveys, 

after telephone recruitment. The BRFSS 

produces state-level information 

primarily on health risk behaviors, 

health conditions, and preventive health 

practices that are associated with 

chronic diseases, infectious diseases, 

and injury. Designed to meet the data 

needs of individual states and 

territories, the CDC sponsors the BRFSS 

information collection project under a 

cooperative agreement with states and 

territories. Under this partnership, 

BRFSS state coordinators determine 

questionnaire content with technical 

and methodological assistance provided 

by CDC. For most states and territories, 

the BRFSS provides the only sources of 

data amenable to state and local level 

health and health risk indicator uses. 

Over time, it has also developed into an 

important data collection system that 

federal agencies rely on for state and 

local health information and to track 

national health objectives such as 

Healthy People. 

CDC bases the BRFSS questionnaire 

on modular design principles to 

accommodate a variety of state-specific 

needs within a common framework. All 

participating states are required to 

administer a standardized core 


lotter on DSK11XQN23PROD with NOTICES1